Illumina, Inc. and the Illumina Corporate Foundation Commit $10 Million to COVID-19 Response and Research

To support public health efforts associated with SARS-CoV-2 surveillance, sequencing and monitoring, Illumina, Inc. is providing in kind donations valued at approximately $5M dollars for instruments and consumables. In addition, we dedicated more than $2M to COVID-19-related research efforts. To advance scientific research, Illumina, Inc. recently released the SARS-CoV-2 Data Toolkit, making it easier for researchers to detect and identify the viral sequence in their samples and contribute their findings to critical public databases. The toolkit is freely accessible on BaseSpace Sequence Hub until October 2020.

“We will do everything we can to deliver next-generation sequencing technology to power the scientists, researchers and clinicians on the frontlines of the fight against COVID-19,” said Francis deSouza, CEO of Illumina. “And, we will not stop there. In addition to our technology, we are dedicated to making a positive impact on humanity through our actions to empower our communities.”

The Illumina Foundation has awarded more than $3M in philanthropic donations, of which $1M has gone to the CDC Foundation COVID Emergency Response Fund, and $2M to local community-based initiatives in the areas where we operate.

“Every day that we are combatting this pandemic, I realize and appreciate how each and every one us can help make a difference,” said Judy Monroe, MD, President and CEO of the CDC Foundation. “The Illumina Foundation’s generous donation will have a significant and positive impact on fighting the coronavirus in communities across the United States.”

The CDC Foundation is currently mobilized to support the Center for Disease Control and Prevention’s response efforts, health departments and others to fight the COVID-19 pandemic.

Native to Illumina’s San Diego roots, the Illumina Foundation donated $1M to the San Diego Foundation COVID-19 Community Response Fund to support distance learning and connectivity for grades K-12, address food security concerns and provide PPE for frontline healthcare professionals. For more than 40 years, the San Diego Foundation has inspired enduring philanthropy and enables community solutions to improve quality of life.

“We are very honored that one of San Diego’s most innovative and fastest growing companies has made a generous commitment to ensuring San Diego school children have the access they need to learn and grow while apart from their teachers and schools,” shared Mark Stuart, President and CEO of The San Diego Foundation.

“With the support of the Illumina Foundation, we have worked to guarantee all students in San Diego have what they need to continue their educational journey and pursue their dreams,” said Cindy Marten, Superintendent of the San Diego Unified School District. “The Illumina Foundation’s donation to the San Diego Foundation will allow us to continue to provide our families the technology and services they need to access information and to continue learning now and into the future. We are very thankful for our long-standing partnership with Illumina.”

Illumina employees have mobilized to take action by selecting local initiatives in their respective communities to donate $1M to their chosen organizations. Additionally, the Illumina Foundation offered a special 200% giving match opportunity and our employees showed an overwhelming response with more than $160,000 raised for various organizations. In support of employees’ desire to directly contribute to their communities, we expanded our paid volunteer time off program from two to 10 days for 2020, and created a directory of virtual volunteering options. Further, to support distance learning, we are offering lessons, activities and videos centered around genomics.

About Illumina, Inc.

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and follow @illumina.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200518005715/en/